These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14809662)

  • 21. [Therapeutic results in osteoarticular tuberculosis; critical studies on the use of coli-vaccine, conteben, PAS, streptomycin and neoteben in 410 patients, with special reference to the limits of chemotherapy].
    KATTHAGEN A
    Z Orthop Ihre Grenzgeb; 1954; 84(4):516-66. PubMed ID: 13196484
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of investigations on the effect of the preparation T-40 (sodium salt of bromosalicylohydroxamic acid) on drug resistance of tuberculosis; preliminary communication].
    HORNUNG S; POLONCZYK M; RAPF T
    Gruzlica (1926); 1956 May; 24(5):335-9. PubMed ID: 13366074
    [No Abstract]   [Full Text] [Related]  

  • 23. Sodium para-aminobenzoate therapy of atopic dermatitis; preliminary report.
    WEINER AL
    J Invest Dermatol; 1950 Oct; 15(4):295-6. PubMed ID: 14779043
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemotherapy of tuberculosis].
    Ther Umsch Med Bibliogr; 1950 Dec; 7(9):142-5. PubMed ID: 14809660
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental contribution to the treatment of pulmonary tuberculosis with paraaminobenzoic acid].
    HARTL W
    Schweiz Z Tuberk; 1954; 11(5):369-77. PubMed ID: 13225730
    [No Abstract]   [Full Text] [Related]  

  • 26. Sodium para-aminobenzoate PABA in the treatment of dermatoses.
    GRAYSON LD; STEINER K
    J Invest Dermatol; 1952 Dec; 19(6):463-6. PubMed ID: 13023019
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic value of the different forms of the sodium salt of para-aminosalicylic acid].
    HEUSGHEM C; VAN CAUWENBERGE H
    J Pharm Belg; 1950; 5(9-10):291-6. PubMed ID: 14795378
    [No Abstract]   [Full Text] [Related]  

  • 28. The oral use of para-amino benzoic acid sodium for hyperthyroidism.
    POPP A
    Marquette Med Rev; 1947 Nov; 13(1):23-6. PubMed ID: 20272666
    [No Abstract]   [Full Text] [Related]  

  • 29. [Subacute lupus erythematosus with the phenomenon of positive L.E. cells, improving with sodium p-aminobenzoate].
    VILANOVA X; DE DULANTO F
    Actas Dermosifiliogr; 1951 Nov; 43(2):154-8. PubMed ID: 14914645
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of catarrhal tonsillitis in infancy with o-hydroxybenzamide (salicylamide) associated with sodium p-aminobenzoate].
    GUASCHINO S
    Gazz Med Ital; 1953 Jan; 112(1):21-2. PubMed ID: 13060598
    [No Abstract]   [Full Text] [Related]  

  • 31. Occurrence of para-aminobenzoic acid and benzocaine as contaminants in sunscreen agents of para-aminobenzoic acid type.
    Bruze M; Fregert S; Gruvberger B
    Photodermatol; 1984 Dec; 1(6):277-85. PubMed ID: 6335917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatic disease; the use of a sodium salicylate and para-aminobenzoic acid combination in various types of rheumatic disease.
    HERZ LF
    Med Times; 1952 May; 80(5):297-303. PubMed ID: 14940309
    [No Abstract]   [Full Text] [Related]  

  • 33. METABOLITES OF RHO-AMINOBENZOIC ACID. IV. STRUCTURE OF METABOLITE I AND ARYL HYDROXYLATION PRIOR HYDROXYMETHYLATION OF THE BENZENE RING.
    SLOANE NH; UNTCH KG
    Biochemistry; 1964 Aug; 3():1160-4. PubMed ID: 14220683
    [No Abstract]   [Full Text] [Related]  

  • 34. [Salicylate and sodium para-aminobenzoate in the treatment of rheumatoid arthritis].
    Herbert G; Renzi N
    Union Med Can; 1957 Jan; 86(1):73-5. PubMed ID: 13409680
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antituberculosis action of succinyl-propaesin and its synergism with vitamin K].
    PISU I; D'AMBROSIO A
    Farmaco Sci Tec; 1950; 5(6):670-80. PubMed ID: 14813293
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antagonism between PAS and PAB].
    NITTI V; DE FRANCISCIS V
    Arch Tisiol Mal Appar Respir; 1951 Dec; 6(12):1091-5. PubMed ID: 14924891
    [No Abstract]   [Full Text] [Related]  

  • 37. [Reversibility of the bacteriostatic action of PAS].
    NITTI V
    Boll Soc Ital Biol Sper; 1951 Dec; 27(12):1679-81. PubMed ID: 14934919
    [No Abstract]   [Full Text] [Related]  

  • 38. [Symptoms of acute poisoning in p-aminosalicylic acid sodium salt therapy].
    MEYER ZU SCHWABEDISSEN O
    Arch Toxikol; 1956; 16(3):150-1. PubMed ID: 13382317
    [No Abstract]   [Full Text] [Related]  

  • 39. Spontaneous formation of immunogenic conjugates by 3-hydroxy-para-aminobenzoic acid--a biotransformation product of procaine and para-aminobenzoic acid.
    Cîrstea M; Suhaciu G; Cîrje M
    Physiologie; 1984; 21(1):25-31. PubMed ID: 6424148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of rheumatic fever; comparison of results obtained with salicylates, cortisone or corticotrophin, phenylbutazone, and combination of sodium salicylate, para-aminobenzoic acid and cortisone.
    KALLIOMAKI L
    Acta Med Scand; 1955 Dec; 152(6):473-8. PubMed ID: 13292167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.